News and Trends 3 Oct 2022
FDA clears Kira Pharmaceuticals’ phase 2 trial for SLE-TMA treatment
Kira Pharmaceuticals says the US Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for KP104, a first-in-class bifunctional biologic that selectively and synergistically targets the…